New Dietary Ingredient Notification Draft Guidance Must Be Withdrawn – CRN and CHPA
This article was originally published in The Tan Sheet
You may also be interested in...
FDA “Undercuts” NDI Guidance Opposition With Compliance Cost Estimate – CRN
OMB approves FDA’s estimate as the official measure for the supplement industry’s anticipated burden in complying with the NDI notification regulation.
NDI Guidance Protects Public Health And Allows Innovation – FDA's Fabricant
Present and former top FDA officials with oversight of dietary supplements defend the draft guidance on new dietary ingredient notifications, saying the document serves important public health priorities and will not be onerous to industry.
Coalition Pushes Congress On OTC Purchases With Health Savings Accounts
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.